AI Article Synopsis

  • Some prebiotics help good bacteria grow, but they can also help some bad bacteria, so researchers tested a specific one called Gal-β1,4-Rha.
  • They found that this prebiotic helps a particular good bacteria grow better while stopping some harmful bacteria from growing.
  • In experiments with mice, using Gal-β1,4-Rha helped prevent weight loss caused by infections, making it a promising option for future health products.

Article Abstract

Certain existing prebiotics meant to facilitate the growth of beneficial bacteria in the intestine also promote the growth of other prominent bacteria. Therefore, the growth-promoting effects of β-galactosides on intestinal bacteria were analyzed. Galactosyl-β1,4-l-rhamnose (Gal-β1,4-Rha) selectively promoted the growth of subsp. 105-A (JCM 31944) has multiple solute-binding proteins belonging to ATP-binding cassette transporters for sugars. Each strain in the library of 11 subsp. mutants, in which each gene of the solute-binding protein was disrupted, was cultured in a medium containing Gal-β1,4-Rha as the sole carbon source, and only the BL105A_0502 gene-disruption mutant showed delayed and reduced growth compared to the wild-type strain. BL105A_0502 homolog is highly conserved in bifidobacteria. In a Gal-β1,4-Rha-containing medium, subsp. JCM 1222, which possesses BLIJ_2090, a homologous protein to BL105A_0502, suppressed the growth of enteric pathogen , whereas the BLIJ_2090 gene-disrupted mutant did not. , administration of and Gal-β1,4-Rha alleviated infection-related weight loss in mice. We have successfully screened Gal-β1,4-Rha as a next-generation prebiotic candidate that specifically promotes the growth of beneficial bacteria without promoting the growth of prominent bacteria and pathogens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475593PMC
http://dx.doi.org/10.1080/19490976.2021.1973835DOI Listing

Publication Analysis

Top Keywords

next-generation prebiotic
8
growth
8
growth beneficial
8
beneficial bacteria
8
growth prominent
8
prominent bacteria
8
bacteria
5
prebiotic promotes
4
promotes selective
4
selective growth
4

Similar Publications

Introduction: Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic disorders of the gastrointestinal tract associated with gut microbiota dysbiosis and inflammation. Serum-derived bovine immunoglobulin (SBI) is used to manage IBS and IBD and has shown prebiotic-like effects in ex vivo models. Re-establishing a healthy gut microbiome with novel treatments like SBI could help treat the underlying causes of these diseases leading to higher and sustained patient response.

View Article and Find Full Text PDF

The increasing global population and the environmental consequences of meat consumption have led to the exploration of alternative sources of protein. Edible insects have gained attention as a sustainable and nutritionally rich meat alternative. We investigated the effects of two commonly consumed insects, larva and pupa, on beneficial gut microbiota growth, using whole 16s metagenome sequencing to assess diet-associated changes.

View Article and Find Full Text PDF

Background: Spent coffee grounds (SCG) are the most abundant waste byproducts generated from coffee beverage production worldwide. Typically, these grounds are seen as waste and end up in landfills. However, SCG contain valuable compounds that can be valorized and used in different applications.

View Article and Find Full Text PDF

Gut commensals play important roles in maintaining the homeostasis of human health. Previous studies indicated that the abundance of in animal hosts was increased by the administration of prebiotics such as polysaccharides purified from iconic oriental medicinal fungi. Subsequently, was found to exert beneficial effects on the amelioration of multiple chronic inflammation-associated diseases.

View Article and Find Full Text PDF

Effects of Marine-Derived Components on Cardiovascular Disease Risk Factors and Gut Microbiota Diversity.

Mar Drugs

November 2024

Department of Pharmacological and Biomolecular Sciences, 'Rodolfo Paoletti', Via Balzaretti 9, Università degli Studi di Milano, 20133 Milano, Italy.

Cardiovascular diseases (CVDs), which comprise coronary heart disease, hypertension, and stroke, collectively represent the number one cause of death globally. Atherosclerosis is the dominant cause of CVDs, and its risk factors are elevated levels of low-density lipoprotein cholesterol and triglycerides, hypertension, cigarette smoking, obesity, and diabetes mellitus. In addition, diverse evidence highlights the role played by inflammation and clonal haematopoiesis, eventually leading to immunity involvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!